Evaluation of Circulating miR‐155, miR‐221, miR‐34a, and miR‐143 for Monitoring Tumor Clearance After Surgery in Colorectal Cancer
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.70166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Hersh Abdul Ham-Karim. Beteiligte Einrichtung: Department of Dentistry, College of Medicine, Komar University of Science and Technology, Sulaymaniyah City, Chaq-Chaq-Qualaraisi, Iraq. Hauptthemen laut MEDLINE: MicroRNAs, Colorectal Neoplasms, Biomarkers, Tumor, Circulating MicroRNA. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) remains one of the leading causes of cancer‐related mortality worldwide. Despite advances in surgery and adjuvant therapy, recurrence after curative resection remains a major challenge, and current surveillance tools such as carcinoembryonic antigen (CEA) and imaging lack sensitivity for detecting minimal residual disease (MRD). Circulating microRNAs (miRNAs) have emerged as promising biomarkers due to their stability in plasma and disease‐specific expression profiles.
Objective
This study aimed to evaluate the clinical relevance of four circulating cell‐free miRNAs—miR‐155, miR‐221, miR‐34a, and miR‐143—for monitoring tumor clearance following surgery in CRC patients.
Methods
Plasma samples were obtained from CRC patients at multiple perioperative time points and compared with samples from healthy controls. Expression levels of the selected miRNAs were quantified using real‐time PCR, normalized to cel‐miR‐39, and analyzed in relation to clinicopathological features. Dynamic postoperative changes and diagnostic performance were assessed, including ROC curve analysis.
Results
Circulating miR‐155 and miR‐221 were significantly upregulated in CRC patients compared with controls, whereas the tumor suppressor miRNAs miR‐34a and miR‐143 were markedly downregulated. Postoperative samples showed progressive normalization of these markers, though variability persisted in a subset of patients. The combined four‐miRNA panel achieved excellent diagnostic accuracy (AUC = 0.999), outperforming CEA in distinguishing CRC from controls. No independent predictive effect of individual miRNAs was demonstrated in multivariate models, but biologically consistent trends were observed.
Conclusion
Circulating miR‐155, miR‐221, miR‐34a, and miR‐143 demonstrate dynamic early postoperative changes and hold promise as minimally invasive biomarkers of short‐term tumor clearance after colorectal cancer surgery. While the combined panel shows strong diagnostic performance at baseline, longer‐term prospective studies with multi‐year follow‐up are required to establish their role in recurrence surveillance alongside established markers such as CEA and ctDNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dentistry, College of Medicine, Komar University of Science and Technology, Sulaymaniyah City, Chaq-Chaq-Qualaraisi, Iraq.
ORCID-Profile: Hersh Abdul Ham-Karim
Zitieren
APA
Ham-Karim, H. A. (2025). Evaluation of Circulating miR‐155, miR‐221, miR‐34a, and miR‐143 for Monitoring Tumor Clearance After Surgery in Colorectal Cancer. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70166
Vancouver
Ham-Karim HA. Evaluation of Circulating miR‐155, miR‐221, miR‐34a, and miR‐143 for Monitoring Tumor Clearance After Surgery in Colorectal Cancer. Journal of Surgical Oncology. 2025. doi:10.1002/jso.70166
BibTeX
@article{HamKarim2025,
author = {Ham-Karim, Hersh Abdul},
title = {Evaluation of Circulating miR‐155, miR‐221, miR‐34a, and miR‐143 for Monitoring Tumor Clearance After Surgery in Colorectal Cancer},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.70166}
}
EUVIMED